Tirzepatide is just as effective in reducing cardiovascular risk driven by central adiposity as that driven by general ...

Novo Nordisk only prices in management's latest year guidance and underestimates the full market potential. See why I rate ...

The GLP-1 medication trend has taken the health and wellness world by storm, largely hailed as a game-changer for weight loss ...

Although the first GLP-1 drug was approved by the US Food and Drug Administration (FDA) in the early 2000s, it wasn't until a ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for ...

Many of these unlawful and unauthorized shipments were explicitly tagged for compounding, which in turn could put many ...

The Food and Drug Administration on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and ...

A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder.

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), originally developed for treating diabetes, work by stimulating insulin secretion and suppressing glucagon release, thereby helping regulate blood ...

A study conducted using electronic health record data from a collective of U.S. health care systems found that most adults ...